Antitrust and Competition
Global businesses feel the growing impact of new competition laws and more sophisticated competition law enforcement around the world. Regardless of whether our clients’ critical competition issues concern developed or emerging jurisdictions — or several jurisdictions at once — Skadden, Arps, Slate, Meagher & Flom LLP and affiliates (“Skadden”) provides timely, seamless assistance with their competition law challenges. Our Antitrust and Competition Group possesses the unique and proven ability to pilot the most sophisticated international competition investigations, merger reviews and litigations through the complexities of this new and shifting framework. Given that today’s competition law enforcers increasingly coordinate, clients should expect the same from their counsel.
Skadden was named the Antitrust Firm of the Year at the 2013 Benchmark Litigation Annual Awards. In 2012, the Financial Times ranked Skadden second in the country in its “US Innovative Lawyers” report, in which we were recognized for our representation of Sprint in successfully opposing AT&T’s acquisition of T-Mobile, and Express Scripts in securing antitrust clearance in its acquisition of Medco. Chambers Global: The World’s Leading Lawyers for Business and U.S. News — Best Lawyers "Best Law Firms" recognize Skadden as one of the top-tier firms in the area of antitrust and competition. We were named among Law360’s Class Action Groups of 2010 and 2011 in recognition of our antitrust class action work, and we were also chosen as one of the publication’s Antitrust Groups of 2011. In addition, we rank among Global Competition Review’s Global Elite in the GCR 100, the publication’s guide to the world’s leading competition law practices.
Our accomplishments on behalf of clients across industries include:
- obtaining timely clearance from antitrust merger control agencies around the globe, including in the U.S., the EU and China, for highly complex mergers, acquisitions and joint ventures;
- the successful defense of major clients in treble-damage U.S. class action litigation, monopolization claims and other government and private U.S. civil disputes;
- guiding companies through U.S. grand jury investigations and EU and EU Member State administrative investigations and court procedures for claims including cartel, price-fixing, dominance, parallel trade and vertical restraints issues;
- advising clients in connection with FTC investigations and administrative proceedings;
- coordinating strategies in leniency applications and cartel investigations in parallel actions by authorities around the world; and
- setting up global antitrust compliance programs, including audits, dawn raid training, in-house counsel workshops and in-person and online compliance training.
To best assist clients, our Antitrust and Competition Group draws on the resources of Skadden’s worldwide platform, which includes focused, integrated services in global mergers and acquisitions, government enforcement and white collar criminal investigations and litigation, trial-level and appellate litigation, and international arbitration. In the U.S., Skadden lawyers assist clients in hearings before the U.S. Congress and federal regulatory agencies, including those in health care, energy, transportation and communications as well as the Department of Defense.
Mergers, Acquisitions and Joint Ventures
Global Scope of Services
Skadden antitrust and competition attorneys plan and execute regulatory filings for mergers, acquisitions and joint ventures in jurisdictions around the globe by marshalling the resources of our worldwide network of offices and working closely with experienced local counsel. This well-developed practice is fundamental to our successful completion of the most complex cross-border transactions (including non-solicited acquisitions).
Our services include:
- coordinating closely and continuously with clients and the M&A team to ensure that obtaining approvals is a primary objective of the overall transaction strategy;
- advising clients regarding the potential antitrust risks of proposed business combinations;
- helping clients structure transactions and draft transaction documents that address those risks; and
- obtaining timely antitrust approval from the Antitrust Division of the U.S. Department of Justice (DOJ), the Federal Trade Commission (FTC), the European Commission, national authorities of the EU Member States, the Ministry of Commerce of the People’s Republic of China and other jurisdictions worldwide.
In the U.S., we handle all types of business combination matters before the DOJ, the FTC and U.S. state attorneys general, including:
advising clients with respect to the requirements of and compliance with the Hart-Scott-Rodino (HSR) Antitrust Improvements Act of 1976;
- working proactively to minimize the time required for any investigation by the FTC, the DOJ or state attorneys general; and
- managing responses to DOJ and FTC requests for additional information, facilitating client compliance quickly, completely and cost effectively.
In the EU, the assistance we provide to clients in notifications to the European Commission includes:
- advising clients on strategic issues in obtaining European Commission approval for all types of transaction structures, consistent with the transactions’ timing demands
- preparing the Form CO as efficiently as possible, in order to minimize the information-gathering burden for clients; and
- obtaining approval consistent with client expectations in terms of timing and result.
In all transactions, we coordinate global notification and approval requirements, working with local Skadden offices and a global network of external counsel, selected exclusively for their antitrust merger control experience and capabilities in their home jurisdictions. Subject to the clients’ preferences, we take a highly centralized approach to rest-of-world notifications, minimizing the information-gathering burden on the client and avoiding redundant data requests and inconsistent use of antitrust merits arguments.
We also assist with the antitrust considerations applicable to due diligence review (information exchanges) and planning for pre- and post-closing integration of the combined companies’ global operations. Our advice regarding potential transaction structures is designed to minimize the demands and substantive risks of competition and foreign investment notifications.
In addition to mergers and acquisitions, we counsel clients regarding the unique challenges presented by the application of global antitrust and competition laws to potential joint ventures, minority investments and other strategic collaborations.
Related Regulatory Matters
A wide variety of businesses retain Skadden in connection with competition issues that arise in connection with regulatory matters. We handle the antitrust aspects of rule-making proceedings and mergers and acquisitions that fall within the jurisdiction of agencies such as the Office of the Comptroller of the Currency, the Federal Reserve Board, the Securities and Exchange Commission, the U.S. Department of Transportation, the Federal Communications Commission, the Federal Energy Regulatory Commission and state insurance departments. In the EU, we regularly counsel clients on a variety of issues, including state aid and public procurement.
Related Litigation
When litigation connected to mergers and other transactions becomes unavoidable, Skadden’s Antitrust and Competition Group advises on disputes globally and in the U.S., managing cases before the federal courts and at the FTC, as well as in the EU General Court and Court of Justice.
Litigation/Controversy
Skadden has an extensive practice defending clients in private litigation, as well as those accused of criminal violations of antitrust and competition laws. Attorneys across offices coordinate closely on multijurisdictional investigations and representing clients in all phases of grand jury matters, as well as in trials, sentencings and appeals.
We have extensive counseling, litigation and jury trial experience in a broad variety of civil and criminal disputes, including treble-damage class action litigation, monopolization claims, price-fixing allegations, Racketeer Influenced and Corrupt Organizations Act (RICO) claims and other matters.
A significant part of Skadden’s U.S. antitrust litigation experience includes a dedicated sports law practice. Our attorneys have served as lead trial counsel to a number of sports leagues, including the National Football League, the National Basketball Association, the National Hockey League, the PGA Tour and the Arena Football League, in a variety of litigations and dispute resolutions involving antitrust claims.
Government Investigations
We routinely advise clients on matters involving investigations before various government agencies. In the EU, we advise clients on Article 101 and Article 102 issues and defend clients against increasingly vigorous enforcement actions brought by the European Commission and, if necessary, in appeals of European Commission decisions concerning these issues to the European courts. We also assist clients with investigations by the DOJ and FTC into alleged violations of the Sherman and Clayton antitrust acts and Section 5 of the FTC Act.
In the context of growing coordination between global antitrust authorities in the field of cartel investigations, Skadden has built a sophisticated practice assisting clients in building integrated strategies to face such investigations. Parallel investigations by authorities in diverse jurisdictions such as the U.S., Canada, the EU, South Africa, South Korea, Japan and Australia require carefully conceived global strategies to address often important differences in procedural requirements and policy priorities, including on issues such as:
-
requirements for leniency applications;
- document production, confidentiality and privilege issues;
- jurisdictions with and without criminal sanctions for cartel behavior; and
- third-party access to evidence produced in other jurisdictions, both in litigation and administrative proceedings.
Counseling
Skadden’s practice also includes counseling and regulatory advice in the U.S. and EU on matters including review of distribution agreements, intellectual property licenses (e.g., patents, know-how, trademarks and copyrights) and other strategic arrangements. We also help clients design, implement and monitor global antitrust audit and compliance programs. Our services in this area include preparing the program; educating client personnel via in-person and interactive teleconference presentations; and conducting audits (surprise or announced) in consultation with clients' internal counsel.
Our Team
Our attorneys have been at the forefront of emerging trends and developments in the antitrust and competition arena and have been recognized for their leadership. In addition to Chambers Global and Chambers USA, numerous publications have named our group members to top antitrust lawyer lists, including Global Counsel, Global Competition Review, The Best Lawyers in America and Legal 500.
Our attorneys have authored hundreds of articles and publications on competition issues, including what is considered the leading treatise on HSR law, Acquisitions Under the Hart-Scott-Rodino Antitrust Improvements Act, Third Edition; the American Bar Association’s Premerger Notification Practice Manual; regular columns for the New York Law Journal; and frequent articles for the Antitrust Law Journal. We often lecture before the Practising Law Institute and other professional organizations, and our group hosts leadership seminars on developments in global competition law.
- Advantest Corporation (Japan) in an approximately $1.1 billion acquisition of Verigy Ltd. (Singapore). Both companies offer automatic test equipment for semiconductor manufacturers.
- Akzo Nobel N.V. (the Netherlands), a paint and chemicals manufacturer, with the U.S. securities laws and antitrust aspects of its $1.3 billion sale of National Starch LLC to Corn Products International, Inc. Both National Starch and Corn Products are manufacturers and sellers of food ingredients from starch.
- Allegheny Energy, Inc. in its $4.7 billion acquisition by FirstEnergy Corp. The deal was structured as a stock-for-stock transaction.
- American Express Company in its approximately $300 million acquisition of Revolution Money Inc., a provider of online payment options.
- BlackRock, Inc. in securing early termination from the FTC and unconditional Phase I clearance from the European Commission in connection with its approximately $20 billion acquisition of Barclays Global Investors from Barclays Bank PLC. Skadden also represented BlackRock in connection with all other competition filings required in connection with this transaction, including in Canada, Mexico, Brazil and Japan.
-
Broadcom Corporation:
- in connection with a number of U.S. and international acquisitions of semiconductor companies, including Provigent Inc. (Israel), Beceem Communications Inc., and Teknovus Inc.; and
- in its approximately $3.7 billion acquisition of NetLogic Microsystems, Inc.
- Bureau of National Affairs, Inc. in connection with the antitrust aspects of its $990 million acquisition by Bloomberg Inc.
- Centennial Communications Corp. in connection with the antitrust review of AT&T Inc.’s $2.8 billion acquisition of Centennial. To resolve the investigation conducted by the DOJ, the FCC and the Office of the Attorney General of Louisiana, AT&T agreed to divest operations in eight service areas in Louisiana and Mississippi, and to honor agreements for roaming on Centennial’s network.
- Cephalon, Inc. in its $6.8 billion acquisition by Teva Pharmaceutical Industries Limited (Israel).
- CF Industries Holdings throughout a three-way, 14-month battle that reshaped the North American fertilizer sector. The contest began in January 2009 when CF Industries launched an unsolicited tender offer for Terra Industries. In the next month, Agrium Inc. launched a separate unsolicited tender offer for CF Industries. When the dust settled, Skadden’s antitrust team won clearance without conditions for CF Industries’ combination with Terra from both U.S. and Canadian authorities. CF Industries and Terra ultimately entered into a negotiated agreement and completed the transaction in April 2010. The combined company is the world’s second-largest nitrogen fertilizer producer, and the transaction had a total value of approximately $4.7 billion.
- Chevron Corporation in its $4.3 billion acquisition of Atlas Energy, Inc., a natural gas developer and producer.
- China National Bluestar (Group) Corporation, a chemical manufacturer, in its $2 billion acquisition of Norway-based silicon producer Elkem AS from Orkla ASA, also of Norway. Skadden’s Antitrust and Competition Group advised Bluestar on the Russian antitrust filing for the transaction.
- Comtech Telecommunications Corp. in its $472.3 million acquisition of CPI International, Inc. Comtech designs, develops, produces and markets innovative products, systems and services for advanced communications solutions in telecommunications transmission, mobile data communications and RF microwave amplifiers. CPI is a leading global supplier of microwave, radio frequency, power and control solutions for defense, communications, medical, scientific and other applications.
- Corning Inc. with the antitrust aspects of its acquisition of MobileAccess Networks, Inc.
- Dentsply International Inc. in connection with the antitrust regulatory approvals in its $1.8 billion acquisition of Astra Tech AB from AstraZeneca. Dentsply is a leading global supplier of professional dental products and Astra Tech is a leading provider of dental implants.
- Diversey Holdings Inc. in connection with the antitrust and regulatory approvals in its $4.3 billion sale to Sealed Air Corporation. Diversey is a leading global provider of cleaning, sanitization and hygiene solutions.
- Duke Energy Corporation and Progress Energy, Inc. in connection with the antitrust and regulatory aspects of their merger agreement, in which Duke Energy agreed to acquire Progress Energy for $13.7 billion. The combined company will be called Duke Energy and will be the largest utility in the United States.
-
Ecolab, Inc.:
- in its approximately $260 million acquisition of O.R. Solutions, Inc., a privately held company. Ecolab provides cleaning, sanitizing, food safety and infection prevention products and services. O.R. Solutions develops and markets surgical fluid warming and cooling systems in the United States; and
- with the antitrust aspects of its $8.1 billion acquisition of Nalco Holding Company, a provider of sustainability services focused on industrial water, energy and air applications.
-
Endo Pharmaceuticals Holdings Inc. in:
- its $2.9 billion acquisition of American Medical Systems, a provider of devices and therapies for male and female pelvic health; and
- its $1.2 billion acquisition of Qualitest Pharmaceuticals, a leading, privately held generics company.
- Entergy Corporation in its approximately $310 million acquisition from Acadia Power Partners of a 50 percent interest in the Acadia generating plant. In its extended review, the Department of Justice focused on incentives and ability to cause competitive effects in wholly regulated electric power markets.
- EMC Corporation in its approximately $2.3 billion acquisition of Isilon Systems, Inc. Both companies are providers of computer hardware data storage devices, services and software.
-
Exelon in:
- its $7.9 billion stock-for-stock merger with Constellation Energy Group, Inc.; and
- the successful antitrust review of its unsolicited offer to acquire NRG Energy, Inc. The proposed acquisition would have created the largest electricity and nuclear generation company in the United States in terms of assets and generation capacity. Skadden’s advocacy on behalf of Exelon addressed several areas of overlapping activities identified by the Department of Justice. Although NRG shareholders ultimately rejected the offer, Skadden’s efforts, including a response to an intensive DOJ second request, left Exelon well positioned to proceed to closing. Skadden also successfully handled regulatory review of the proposed acquisition by the Federal Energy Regulatory Commission.
-
Express Scripts, Inc. in:
- its approximately $4.7 billion acquisition of WellPoint, Inc.’s NextRx subsidiaries. Both Express Scripts and NextRx provide pharmacy benefit management services; and
- its $29.1 billion acquisition of Medco Health Solutions, Inc. The deal is the second-largest announced transaction of the year.
- Foundation Coal Holdings, Inc. in its approximately $2 billion acquisition by Alpha Natural Resources, Inc. Both Foundation Coal Holdings, Inc. and Alpha Natural Resources, Inc. are coal mining companies. The transaction was reviewed by the Federal Trade Commission, which focused on product and geographic market definition issues relating to thermal coal and metallurgical coal. Aided by Skadden’s efforts, the initial waiting period under the HSR Act expired without action by the FTC.
- Hitachi, Ltd. in the $4.3 billion sale of its wholly owned subsidiary, Hitachi Global Storage Technologies, to Western Digital.
- IAC/InterActiveCorp, an owner of Internet shopping websites, in its US$113 million sale of Match.Com International, Limited (United Kingdom), the European operations of online dating website Match.com LLC, to Meetic SA (France), a provider of online dating services. IAC/InterActiveCorp received a 27 percent stake in Meetic and a deferred payment of €5.3 million.
- McKesson Corporation in connection with its $2.16 billion acquisition of US Oncology Holdings, Inc. McKesson, currently ranked 15th on the Fortune 500, is a health care services and information technology company. US Oncology Holdings is a leading integrated oncology company.
-
MDS Inc. (Canada), a biotechnology company, in:
- the $650 million sale of its subsidiary MDS Analytical Technologies (Canada) to Danaher Corporation, a manufacturer of tools, industrial equipment and medical equipment. In a related deal, Life Technologies Corp. sold its 50 percent stake in AB Sciex to Danaher. MDS sells a variety of innovative medical technology products, and AB Sciex is the market leader in mass spectrometry for medical uses. The total value of the deals was $1.1 billion. The parties were able to secure worldwide clearance for the transaction quickly, with only the divestiture of MDS’s Arcturus laser microdissection product line; and
- its sale of its Pharma Services Late Stage Phase II-IV operations to INC Research Inc.
- Meadville Holdings Limited (Hong Kong) in the approximately US$521 million sale of its printed circuit board business to TTM Technologies, Inc. Skadden also represented Meadville Holdings in the approximately US$359 million sale of its laminate and prepreg manufacturing business to Tang Hsiang Chien, the controlling shareholder of Meadville Holdings. Both Meadville Holdings and TTM Technologies are manufacturers of electronic components. This transaction was the first in which shares of a U.S.-listed company have been used as consideration in a Hong Kong public M&A transaction.
- Merck KGaA (Germany) in its approximately US$7.2 billion acquisition of Millipore Corporation, a life sciences company. Skadden’s Antitrust and Competition Group advised on antitrust merger review and clearance in the U.S. under the HSR Act as well as competition filings in the EC and in a number of other countries.
- Micrus Endovascular Corporation in its approximately $480 million acquisition by Johnson & Johnson. Micrus is a global developer and manufacturer of minimally invasive devices to address hemorrhagic and ischemic stroke.
- Northeast Utilities in its merger-of-equals with NSTAR to create one of the nation’s largest electric utilities with an enterprise value of $17.5 billion. The combined company will retain the name Northeast Utilities.
- Novell, Inc. in its acquisition by Attachmate Corporation and in the concurrent sale of its intellectual property assets to CPTN Holdings LLC, a consortium of technology companies organized by Microsoft Corporation. The two transactions were valued at $2.2 billion.
- OPI Products Inc. and its owners in connection with the proposed sale of the company to Coty Inc. OPI is a leader in professional nail salon products. Coty is a leading global beauty company.
- OSI Pharmaceuticals, Inc. in its $4 billion acquisition by Astellas Pharma Inc. (Japan).
- Pacific Century Group (PCG), an Asia-based private investment group, in its approximately $500 million acquisition of a portion of American International Group, Inc.’s (AIG) investment advisory and asset management business. The transaction presented a number of complex jurisdictional issues and required close coordination with local counsel on a worldwide basis.
- Pactiv Corporation in its approximately $6 billion acquisition by Reynolds Group Holdings Limited. Both companies are providers of packaging and storage products for the consumer and food services industries.
- Permira in its sale of Jet Aviation to General Dynamics to create the leading global provider of certain specialized services for business jet owners and operators. After a brief review, the DOJ closed its investigation without conditions.
- Pfizer Inc. in its acquisition of Ferrosan’s consumer health care business, which includes dietary supplements and lifestyle products, from Altor 2003 Fund GP Limited. Based in Copenhagen, Ferrosan sells products primarily in the Nordic region and the emerging markets of Russia and Central and Eastern Europe.
- Pierre Foods, Inc. in a merger with Advance Foods Company and its joint venture, Advance Brands. Both parties are manufacturers of value added protein products. Pierre is an Oaktree company.
- Revlon Inc. with the antitrust aspects of its $60 million acquisition of certain assets from Mirage Cosmetics, Inc.
- Rockwood Specialties in its acquisition of the color pigments business of Elementis plc. The extensive investigation of the deal by the Federal Trade Commission focused on the parties’ very high past market shares in pigments essential to certain applications, such as pharmaceuticals and high-quality paints. Skadden’s advocacy successfully demonstrated significant dynamism and new entry into the affected markets, and ultimately resulted in the parties’ ability to close the deal without divestitures or other conditions.
- RRI Energy, Inc. in its $1.6 billion merger-of-equals with Mirant Corporation to form GenOn Energy, one of the largest independent power producers in the United States.
- Southwest Airlines Co. in connection with the DOJ investigation of its acquisition of AirTran Holdings, Inc.
-
Stryker Corporation in:
- its $1.5 billion acquisition of Boston Scientific Corporation’s neurovascular business; and
- its $316 million acquisition of Orthovita, Inc.
- TANDBERG, the world’s largest provider of high-quality videoconferencing solutions, in securing antitrust approvals in the U.S. and Europe for its acquisition by Cisco Systems. The parties were the two most prominent providers of certain sophisticated high-definition videoconferencing products known as “telepresence” systems. Skadden’s successful global advocacy led the Department of Justice and the European Commission to end nearly six months of intensive investigation with minimal remedial conditions. In announcing the DOJ’s closing of their investigation, Assistant Attorney General for Antitrust Christine Varney praised the parties for helping to facilitate what she hailed as “a model of international cooperation between the United States and the European Commission.”
- Valeant Pharmaceuticals International in its $3.2 billion merger with Biovail Corporation.
- Veritas Capital in its $525 million acquisition of CPI International, Inc. CPI is the parent company of Communications & Power Industries, Inc., a leading provider of microwave, radio frequency, power and control solutions for defense, communications, medical, scientific and other applications.
-
Watson Pharmaceuticals, Inc., a leading generic and specialty pharmaceutical company:
- in securing antitrust approval for its $1.75 billion acquisition of Arrow Group, another prominent pharmaceutical company. Skadden secured approval for the transaction in five months, effectively allowing the acquisition to proceed with the limited divestiture of three minor products; and
- with the antitrust aspects of its approximately $92.5 million acquisition of the U.S. rights to the Crinone® and Priocheve® progesterone gel product line from Columbia Laboratories, Inc.
- XTO Energy Inc. in its $41 billion acquisition by Exxon Mobil Corporation — the sixth-largest M&A transaction in 2009 worldwide and the biggest energy deal since 2006. XTO is a domestic oil and natural gas producer engaged in the acquisition, exploitation and development of oil and natural gas properties in the United States, with a focus on unconventional natural gas properties. Exxon Mobil is the largest publicly traded international oil and gas company. Working closely with Exxon Mobil’s counsel, Skadden helped the FTC understand quickly that the proposed transaction would not likely harm competition substantially, and the HSR Act waiting period was allowed to expire. Skadden also helped XTO obtain clearance for the transaction from the Dutch Competition Authority.
- Air France-KLM S.A. in its joint venture agreement with Delta Air Lines, Inc. to share revenues and costs on their trans-Atlantic routes.
- Dow Jones & Company and CME Group in securing HSR approvals (including an early termination of the HSR waiting period) for the creation of CME Group Index Services LLC, a new joint venture. The joint venture owns the Dow Jones Indexes, which includes The Dow Jones Industrial Average and approximately 130,000 other index properties covering 65 markets. The transaction valued the Dow Jones Indexes at $675 million and gave CME Group a 90 percent ownership interest in the newly created joint venture. Skadden, with the consent of the parties, represented both parties for purposes of securing the Hart-Scott-Rodino Act regulatory approval. The transaction was reviewed by the Antitrust Division of the Department of Justice. As a result of Skadden’s efforts, the transaction received early termination of the HSR waiting period.
- Scripps Networks Interactive, Inc., an operator of television networks and related Internet business, in its joint venture with Cox Communications Inc. to acquire a controlling interest in The Travel Channel, L.L.C.
- Yahoo! in connection with obtaining antitrust clearances for its search transaction with Microsoft, which was first announced in late July 2009. Pursuant to this agreement, Yahoo! will provide Microsoft with an exclusive license to certain search technology, and Microsoft will provide Yahoo! with the same algorithmic and paid search results as will be available through Microsoft’s search engine Bing. Yahoo! will continue to innovate around those results by integrating Yahoo! content, enhanced listings and tools to tailor the experience for Yahoo! users.
- a global pharmaceutical company in its discussions with another pharmaceutical manufacturer regarding several potential joint collaborations.
- Advantest Corporation (Japan) in an approximately $1.1 billion acquisition of Verigy Ltd. (Singapore). Both companies offer automatic test equipment for semiconductor manufacturers.
- Akzo Nobel N.V. (the Netherlands), a paint and chemicals manufacturer, with the U.S. securities laws and antitrust aspects of its $1.3 billion sale of National Starch LLC to Corn Products International, Inc. Both National Starch and Corn Products are manufacturers and sellers of food ingredients from starch.
- Allegheny Energy, Inc. in its $4.7 billion acquisition by FirstEnergy Corp. The deal was structured as a stock-for-stock transaction.
- American Express Company in its approximately $300 million acquisition of Revolution Money Inc., a provider of online payment options.
- BlackRock, Inc. in securing early termination from the FTC and unconditional Phase I clearance from the European Commission in connection with its approximately $20 billion acquisition of Barclays Global Investors from Barclays Bank PLC. Skadden also represented BlackRock in connection with all other competition filings required in connection with this transaction, including in Canada, Mexico, Brazil and Japan.
- Broadcom Corporation:
- in connection with a number of U.S. and international acquisitions of semiconductor companies, including Provigent Inc. (Israel), Beceem Communications Inc., and Teknovus Inc.; and
- in its approximately $3.7 billion acquisition of NetLogic Microsystems, Inc.
- Bureau of National Affairs, Inc. in connection with the antitrust aspects of its $990 million acquisition by Bloomberg Inc.
- Centennial Communications Corp. in connection with the antitrust review of AT&T Inc.’s $2.8 billion acquisition of Centennial. To resolve the investigation conducted by the DOJ, the FCC and the Office of the Attorney General of Louisiana, AT&T agreed to divest operations in eight service areas in Louisiana and Mississippi, and to honor agreements for roaming on Centennial’s network.
- Cephalon, Inc. in its $6.8 billion acquisition by Teva Pharmaceutical Industries Limited (Israel).
- CF Industries Holdings throughout a three-way, 14-month battle that reshaped the North American fertilizer sector. The contest began in January 2009 when CF Industries launched an unsolicited tender offer for Terra Industries. In the next month, Agrium Inc. launched a separate unsolicited tender offer for CF Industries. When the dust settled, Skadden’s antitrust team won clearance without conditions for CF Industries’ combination with Terra from both U.S. and Canadian authorities. CF Industries and Terra ultimately entered into a negotiated agreement and completed the transaction in April 2010. The combined company is the world’s second-largest nitrogen fertilizer producer, and the transaction had a total value of approximately $4.7 billion.
- Chevron Corporation in its $4.3 billion acquisition of Atlas Energy, Inc., a natural gas developer and producer.
- China National Bluestar (Group) Corporation, a chemical manufacturer, in its $2 billion acquisition of Norway-based silicon producer Elkem AS from Orkla ASA, also of Norway. Skadden’s Antitrust and Competition Group advised Bluestar on the Russian antitrust filing for the transaction.
- Comtech Telecommunications Corp. in its $472.3 million acquisition of CPI International, Inc. Comtech designs, develops, produces and markets innovative products, systems and services for advanced communications solutions in telecommunications transmission, mobile data communications and RF microwave amplifiers. CPI is a leading global supplier of microwave, radio frequency, power and control solutions for defense, communications, medical, scientific and other applications.
- Corning Inc. with the antitrust aspects of its acquisition of MobileAccess Networks, Inc.
- Dentsply International Inc. in connection with the antitrust regulatory approvals in its $1.8 billion acquisition of Astra Tech AB from AstraZeneca. Dentsply is a leading global supplier of professional dental products and Astra Tech is a leading provider of dental implants.
- Diversey Holdings Inc. in connection with the antitrust and regulatory approvals in its $4.3 billion sale to Sealed Air Corporation. Diversey is a leading global provider of cleaning, sanitization and hygiene solutions.
- Duke Energy Corporation and Progress Energy, Inc. in connection with the antitrust and regulatory aspects of their merger agreement, in which Duke Energy agreed to acquire Progress Energy for $13.7 billion. The combined company will be called Duke Energy and will be the largest utility in the United States.
-
Ecolab, Inc.:
- in its approximately $260 million acquisition of O.R. Solutions, Inc., a privately held company. Ecolab provides cleaning, sanitizing, food safety and infection prevention products and services. O.R. Solutions develops and markets surgical fluid warming and cooling systems in the United States; and
- with the antitrust aspects of its $8.1 billion acquisition of Nalco Holding Company, a provider of sustainability services focused on industrial water, energy and air applications.
-
Endo Pharmaceuticals Holdings Inc. in:
- its $2.9 billion acquisition of American Medical Systems, a provider of devices and therapies for male and female pelvic health; and
- its $1.2 billion acquisition of Qualitest Pharmaceuticals, a leading, privately held generics company.
- Entergy Corporation in its approximately $310 million acquisition from Acadia Power Partners of a 50 percent interest in the Acadia generating plant. In its extended review, the Department of Justice focused on incentives and ability to cause competitive effects in wholly regulated electric power markets.
- EMC Corporation in its approximately $2.3 billion acquisition of Isilon Systems, Inc. Both companies are providers of computer hardware data storage devices, services and software.
-
Exelon in:
- its $7.9 billion stock-for-stock merger with Constellation Energy Group, Inc.; and
- the successful antitrust review of its unsolicited offer to acquire NRG Energy, Inc. The proposed acquisition would have created the largest electricity and nuclear generation company in the United States in terms of assets and generation capacity. Skadden’s advocacy on behalf of Exelon addressed several areas of overlapping activities identified by the Department of Justice. Although NRG shareholders ultimately rejected the offer, Skadden’s efforts, including a response to an intensive DOJ second request, left Exelon well positioned to proceed to closing. Skadden also successfully handled regulatory review of the proposed acquisition by the Federal Energy Regulatory Commission.
-
Express Scripts, Inc. in:
- its approximately $4.7 billion acquisition of WellPoint, Inc.’s NextRx subsidiaries. Both Express Scripts and NextRx provide pharmacy benefit management services; and
- its $29.1 billion acquisition of Medco Health Solutions, Inc. The deal is the second-largest announced transaction of the year.
- Foundation Coal Holdings, Inc. in its approximately $2 billion acquisition by Alpha Natural Resources, Inc. Both Foundation Coal Holdings, Inc. and Alpha Natural Resources, Inc. are coal mining companies. The transaction was reviewed by the Federal Trade Commission, which focused on product and geographic market definition issues relating to thermal coal and metallurgical coal. Aided by Skadden’s efforts, the initial waiting period under the HSR Act expired without action by the FTC.
- Hitachi, Ltd. in the $4.3 billion sale of its wholly owned subsidiary, Hitachi Global Storage Technologies, to Western Digital.
- IAC/InterActiveCorp, an owner of Internet shopping websites, in its US$113 million sale of Match.Com International, Limited (United Kingdom), the European operations of online dating website Match.com LLC, to Meetic SA (France), a provider of online dating services. IAC/InterActiveCorp received a 27 percent stake in Meetic and a deferred payment of €5.3 million.
- McKesson Corporation in connection with its $2.16 billion acquisition of US Oncology Holdings, Inc. McKesson, currently ranked 15th on the Fortune 500, is a health care services and information technology company. US Oncology Holdings is a leading integrated oncology company.
-
MDS Inc. (Canada), a biotechnology company, in:
- the $650 million sale of its subsidiary MDS Analytical Technologies (Canada) to Danaher Corporation, a manufacturer of tools, industrial equipment and medical equipment. In a related deal, Life Technologies Corp. sold its 50 percent stake in AB Sciex to Danaher. MDS sells a variety of innovative medical technology products, and AB Sciex is the market leader in mass spectrometry for medical uses. The total value of the deals was $1.1 billion. The parties were able to secure worldwide clearance for the transaction quickly, with only the divestiture of MDS’s Arcturus laser microdissection product line; and
- its sale of its Pharma Services Late Stage Phase II-IV operations to INC Research Inc.
- Meadville Holdings Limited (Hong Kong) in the approximately US$521 million sale of its printed circuit board business to TTM Technologies, Inc. Skadden also represented Meadville Holdings in the approximately US$359 million sale of its laminate and prepreg manufacturing business to Tang Hsiang Chien, the controlling shareholder of Meadville Holdings. Both Meadville Holdings and TTM Technologies are manufacturers of electronic components. This transaction was the first in which shares of a U.S.-listed company have been used as consideration in a Hong Kong public M&A transaction.
- Merck KGaA (Germany) in its approximately US$7.2 billion acquisition of Millipore Corporation, a life sciences company. Skadden’s Antitrust and Competition Group advised on antitrust merger review and clearance in the U.S. under the HSR Act as well as competition filings in the EC and in a number of other countries.
- Micrus Endovascular Corporation in its approximately $480 million acquisition by Johnson & Johnson. Micrus is a global developer and manufacturer of minimally invasive devices to address hemorrhagic and ischemic stroke.
- Northeast Utilities in its merger-of-equals with NSTAR to create one of the nation’s largest electric utilities with an enterprise value of $17.5 billion. The combined company will retain the name Northeast Utilities.
- Novell, Inc. in its acquisition by Attachmate Corporation and in the concurrent sale of its intellectual property assets to CPTN Holdings LLC, a consortium of technology companies organized by Microsoft Corporation. The two transactions were valued at $2.2 billion.
- OPI Products Inc. and its owners in connection with the proposed sale of the company to Coty Inc. OPI is a leader in professional nail salon products. Coty is a leading global beauty company.
- OSI Pharmaceuticals, Inc. in its $4 billion acquisition by Astellas Pharma Inc. (Japan).
- Pacific Century Group (PCG), an Asia-based private investment group, in its approximately $500 million acquisition of a portion of American International Group, Inc.’s (AIG) investment advisory and asset management business. The transaction presented a number of complex jurisdictional issues and required close coordination with local counsel on a worldwide basis.
- Pactiv Corporation in its approximately $6 billion acquisition by Reynolds Group Holdings Limited. Both companies are providers of packaging and storage products for the consumer and food services industries.
- Permira in its sale of Jet Aviation to General Dynamics to create the leading global provider of certain specialized services for business jet owners and operators. After a brief review, the DOJ closed its investigation without conditions.
- Pfizer Inc. in its acquisition of Ferrosan’s consumer health care business, which includes dietary supplements and lifestyle products, from Altor 2003 Fund GP Limited. Based in Copenhagen, Ferrosan sells products primarily in the Nordic region and the emerging markets of Russia and Central and Eastern Europe.
- Pierre Foods, Inc. in a merger with Advance Foods Company and its joint venture, Advance Brands. Both parties are manufacturers of value added protein products. Pierre is an Oaktree company.
- Revlon Inc. with the antitrust aspects of its $60 million acquisition of certain assets from Mirage Cosmetics, Inc.
- Rockwood Specialties in its acquisition of the color pigments business of Elementis plc. The extensive investigation of the deal by the Federal Trade Commission focused on the parties’ very high past market shares in pigments essential to certain applications, such as pharmaceuticals and high-quality paints. Skadden’s advocacy successfully demonstrated significant dynamism and new entry into the affected markets, and ultimately resulted in the parties’ ability to close the deal without divestitures or other conditions.
- RRI Energy, Inc. in its $1.6 billion merger-of-equals with Mirant Corporation to form GenOn Energy, one of the largest independent power producers in the United States.
- Southwest Airlines Co. in connection with the DOJ investigation of its acquisition of AirTran Holdings, Inc.
-
Stryker Corporation in:
- its $1.5 billion acquisition of Boston Scientific Corporation’s neurovascular business; and
- its $316 million acquisition of Orthovita, Inc.
- TANDBERG, the world’s largest provider of high-quality videoconferencing solutions, in securing antitrust approvals in the U.S. and Europe for its acquisition by Cisco Systems. The parties were the two most prominent providers of certain sophisticated high-definition videoconferencing products known as “telepresence” systems. Skadden’s successful global advocacy led the Department of Justice and the European Commission to end nearly six months of intensive investigation with minimal remedial conditions. In announcing the DOJ’s closing of their investigation, Assistant Attorney General for Antitrust Christine Varney praised the parties for helping to facilitate what she hailed as “a model of international cooperation between the United States and the European Commission.”
- Valeant Pharmaceuticals International in its $3.2 billion merger with Biovail Corporation.
- Veritas Capital in its $525 million acquisition of CPI International, Inc. CPI is the parent company of Communications & Power Industries, Inc., a leading provider of microwave, radio frequency, power and control solutions for defense, communications, medical, scientific and other applications.
-
Watson Pharmaceuticals, Inc., a leading generic and specialty pharmaceutical company:
- in securing antitrust approval for its $1.75 billion acquisition of Arrow Group, another prominent pharmaceutical company. Skadden secured approval for the transaction in five months, effectively allowing the acquisition to proceed with the limited divestiture of three minor products; and
- with the antitrust aspects of its approximately $92.5 million acquisition of the U.S. rights to the Crinone® and Priocheve® progesterone gel product line from Columbia Laboratories, Inc.
- XTO Energy Inc. in its $41 billion acquisition by Exxon Mobil Corporation — the sixth-largest M&A transaction in 2009 worldwide and the biggest energy deal since 2006. XTO is a domestic oil and natural gas producer engaged in the acquisition, exploitation and development of oil and natural gas properties in the United States, with a focus on unconventional natural gas properties. Exxon Mobil is the largest publicly traded international oil and gas company. Working closely with Exxon Mobil’s counsel, Skadden helped the FTC understand quickly that the proposed transaction would not likely harm competition substantially, and the HSR Act waiting period was allowed to expire. Skadden also helped XTO obtain clearance for the transaction from the Dutch Competition Authority.
- Ainsworth Lumber Co. Ltd. (Canada) in the settlement of a price-fixing case in the U.S. District Court for the Eastern District of Pennsylvania by direct and indirect purchasers of oriented strand board.
- Amylin Pharmaceuticals, Inc. in an antitrust lawsuit against Eli Lilly and Company in the U.S. District Court for the Southern District of California alleging breach of a commercialization agreement for diabetes drugs.
- AXIS Capital Holdings Ltd. in class action litigation in the U.S. District Court for the District of New Jersey alleging antitrust and RICO claims with respect to a purported scheme to reduce or eliminate competition for commercial insurance purchased through brokers. The case has been substantially narrowed by the Third Circuit.
- Cemex Inc. in a putative class action brought in federal district court in Florida by direct and indirect purchasers alleging price fixing, territorial and customer allocation in the cement and ready-mix concrete industries. In response to the defendant’s motion to dismiss, the court has substantially narrowed the claims in this case.
- Chase Paymentech Solutions, LLC in the settlement of a lawsuit in the U.S. District Court for the District of New Jersey brought by Heartland Payment Systems, Inc. in connection with alleged violations of the Sherman Act.
- China National Minerals Co., Ltd. in the dismissal of a purported class action in the District of New Jersey alleging that China National, along with other Chinese magnesite producers and exporters, engaged in a conspiracy to fix the prices of magnesite exported from China to the United States. All of the defendants were Chinese nationals and all of the alleged illegal conduct occurred in China. The judge dismissed for lack of subject matter jurisdiction under the Foreign Trade Antitrust Improvements Act (FTAIA), finding first that the plaintiffs did not sufficiently allege that the defendants were “importers” into the U.S. (as opposed to exporters from China). The judge further ruled that the plaintiffs failed to allege that the defendants’ export of magnesite from China had a “direct, substantial and reasonably foreseeable effect” on U.S. commerce, as required by the FTAIA, because the plaintiffs’ own allegations and supporting evidence demonstrated that the alleged magnesite cartel was focused on a global (rather than U.S.) market and that the U.S. comprised a small percentage of China’s total magnesite exports. The U.S. Court of Appeals for the Third Circuit subsequently vacated the dismissal and remanded the case for further consideration for dismissal by the district court. Skadden is representing China National in its motion for rehearingen banc.
- CIBC World Markets Corp., Cowen and Company, LLC, ING Barings LLC and ABN AMRO Inc. in putative class actions of issuers and purchasers of initial public offerings alleging that the defendant IPO underwriters, including our clients, violated the antitrust laws by allegedly agreeing to fix the fees charged to issuers of IPOs valued between $20 million to $80 million at 7 percent of the proceeds of the IPOs (In re Issuer Plaintiff Public Offering Antitrust Litigation (S.D.N.Y) and In re Public Offering Fee Antitrust Litigation (S.D.N.Y.)). The actions were resolved successfully, following a number of notable decisions during the course of the litigation.
-
De Beers in:
- an appeal to the Third Circuit of a $295 million settlement of seven antitrust class actions relating to gem diamonds;
- a treble-damage antitrust suit in S.D.N.Y. by a former sightholder alleging overcharges in the price of gem diamonds. In February 2010, the court dismissed claims against eight of the defendants represented by the firm on preliminary motions; and
- a class action litigation in the Supreme Court of British Columbia accusing De Beers and others of engaging in anticompetitive practices affecting the gem grade diamond industry in Canada.
- Domfoam International, Inc. and Valle Foam Industries (1995) Inc.(Canada) in connection with more than 40 antitrust price-fixing lawsuits regarding an alleged conspiracy among manufacturers of polyurethane foam, consolidated for pretrial purposes in the U.S. District Court for the Northern District of Ohio. The case is currently in the preliminary stages.
- DRS C3 Systems, Inc. (United States) in the Federal Court of Australia, New South Wales District, in civil proceedings brought by the Australian Competition and Consumer Commission and a settlement in February 2010 based on allegations of a violation of Australia’s Trade Practices Act of 1974.
- Energy Transfer Partners, L.P. in a putative class action filed by natural gas sellers claiming unlawful restraint of trade, monopolization through predatory pricing and common law fraud. The court concluded that the plaintiffs failed adequately to allege common law fraud, a conspiracy, predatory pricing, a plausible relevant antitrust market or any cognizable antitrust injury. The plaintiffs appealed the district’s dismissal of the common law fraud claims, and the Fifth Circuit affirmed the dismissal.
- Flint Energy Services Ltd. (Canada) in the settlement of a government antitrust prosecution in connection with pipeline regulations.
- HarperCollins Publishers in class actions alleging antitrust violations relating to the sale of e-books.
- Horizon Lines in a multidistrict treble-damage litigation involving allegations of price fixing in connection with ocean transportation in domestic trades. The U.S. District Court significantly reduced a criminal fine and approved settlement of treble-damage litigation.
- JAKKS Pacific, Inc., a manufacturer of toys, in the dismissal of a lawsuit in the U.S. District Court for the Southern District of New York and in Connecticut state court, in which World Wrestling Entertainment, Inc. alleged claims in connection with antitrust and RICO violations, including racketeering, bribery and money-laundering. The U.S. Court of Appeals for the Second Circuit affirmed the dismissal.
-
JPMorgan Chase & Co. in:
- a nationwide putative class action alleging a conspiracy among consumer lenders, credit reporting bureaus and credit scoring agencies to restrict the availability of consumer loans and to inflate and fix loan pricing through the exchange of consumer creditworthiness information and credit scores. The Court granted JPMorgan’s motion to dismiss the complaint, with prejudice. Black v. JPMorgan Chase & Co., et al. (W.D. Pa.) (2010);
- what is the largest antitrust class action in history — a putative nationwide class action of millions of merchants alleging a conspiracy in violation of Section 1 of the Sherman Act, between and among Visa, MasterCard and their member banks, to fix and artificially raise interchange fees, which affect the discount rate that a merchant pays on each transaction made with a payment card. The plaintiffs also allege monopolization by the networks under Section 2 of the Sherman Act, and violation of Section 7 of the Clayton Act arising from each network’s reorganization. In addition to damages, the plaintiffs seek injunctive relief against certain network point-of-sale rules. In re Payment Card Interchange Fee & Merchant Discount Antitrust Litigation (E.D.N.Y.) (MDL) (2006); and
- a nationwide putative class action alleging a conspiracy among various private equity and securities firms to fix the bid processes in connection with various leveraged buyout transactions. Dahl et al. v. Bain Capital Partners, LLC (D. Mass.) (2007).
- KeySpan Corporation, now part of National Grid plc, in connection with a negotiated settlement of a Department of Justice investigation into allegations that a KeySpan financial swap transaction kept electricity prices artificially high in New York City, and in connection with related putative state and federal class actions in New York, each seeking at least $118 million in damages. The U.S. District Court for the Southern District of New York court granted KeySpan’s motion to dismiss with prejudice on standing and filed rate doctrine grounds.
-
KLM Royal Dutch Airlines (KLM) in:
- the dismissal of a putative class action alleging that KLM and several other international airlines fixed surcharges on certain passenger routes between Europe and Asia on the basis that the court lacked subject matter jurisdiction pursuant to the Foreign Trade Antitrust Improvements Act;
- the dismissal of a putative class action alleging that KLM and several other international airlines fixed surcharges on certain passenger routes between Europe and the United States on the basis that the plaintiffs failed to state a claim under Rule 12(b)(6); and
- a settlement on favorable terms of multidistrict treble damage actions in which KLM and several other major international airlines are alleged to have violated federal, state and foreign antitrust laws in connection with the setting of certain surcharges for the provision of air cargo shipping services.
- Merrill Lynch & Co., Inc. in the dismissal of class action suits brought in the U.S. District Court for the Southern District of New York by issuers and investors of auction rate securities alleging antitrust violations. The plaintiffs alleged that several major financial institutions had acted collectively to withdraw support for the auction rate securities market, in violation of Section 1 of the Sherman Act. The judge agreed with the defendants’ argument that the plaintiffs’ claims were impliedly precluded by federal securities laws.
- Merrill, Lynch, Pierce, Fenner & Smith Incorporated in the U.S. Court of Appeals for the Second Circuit, which affirmed the dismissal of a putative class action alleging collusion among certain financial institutions that serve as “prime brokers” in connection with short sale transactions. The plaintiff-appellant, short seller Electronic Trading Group, LLC, alleged that prime brokers arbitrarily had designated certain securities as “hard to borrow” and then fixed the price for borrowing them in violation of the Sherman Act. The U.S. District Court for the Southern District of New York had dismissed the complaint on the grounds that antitrust liability was impliedly precluded by the federal securities laws.
- Morgan Stanley in a putative class action by state, local and municipal government entities, government agencies and private entities alleging antitrust violations against Wall Street banks and other investment firms for allegedly conspiring to fix, maintain or stabilize the price of municipal derivatives and to engage in bid rigging.
- Norfolk Southern Corporation in multidistrict treble-damage actions in which Norfolk Southern and the other major railroads are alleged to have violated federal and state antitrust laws in connection with the assessment of rail freight fuel surcharges. The U.S. District Court for the District of Columbia dismissed the case with respect to the state indirect purchaser claims, ruling that the claims were preempted by the Interstate Commerce Commission Termination Act of 1995. In 2010, the U.S. Court of Appeals for the District of Columbia affirmed the dismissal. Litigation of the federal direct purchaser claims is ongoing.
- Pfizer Inc. in connection with a putative class action and opt-out claims by direct purchasers of Neurontin alleging monopolistic conduct.
- Realogy Corporation, Century 21 Real Estate LLC and Coldwell Banker Real Estate LLC in an antitrust class action alleging that real estate brokers fixed brokerage commissions charged to sellers of residential real estate in Kentucky.
- SanDisk Corp. in two cases in defense of antitrust counterclaims relating to the company’s licensing of its patented flash memory technology.
- U.S. International Media, LLC in connection with three tortious interference with contract lawsuits brought by various entities that represent television stations in the sale of spot advertising, in the Supreme Court of the State of New York. In response, USIM filed antitrust counterclaims against these entities alleging a conspiracy in restraint of trade in violation of the Donnelly Act and successfully defended against the plaintiffs’ motion to dismiss, which the court denied in April 2011.
-
Watson Pharmaceuticals, Inc., a generic pharmaceutical company, in:
- defending an antitrust suit brought by the Federal Trade Commission challenging Watson’s 2006 settlement of Hatch-Waxman patent litigation relating to the drug AndroGel®. The suit — initially brought in the Central District of California as part of the FTC’s avowed strategy to halt the “permissive” approach to reverse-payment settlements that has been adopted by three Circuit Courts of Appeal — was dismissed by the U.S. District Court for the Northern District of Georgia after a successful motion to transfer. Skadden also represents Watson in nine follow-on private actions brought by various groups of purchaser plaintiffs; and
- representing the company and CEO Paul Bisaro in securing the right to take discovery against the Federal Trade Commission in connection with a dispute over subpoena enforcement. We believe that this is the first time discovery has ever been allowed against the FTC during an investigation.
- XM Satellite Radio Inc. in a putative class action lawsuit filed against it in the United States District Court for the Southern District of New York by former XM customer Richard Vaccariello. In the lawsuit, Mr. Vaccariello alleges that XM fails to provide customers with notice of the renewal of their service contracts for XM satellite radio as required by New York General Obligations Law Section 5-903 and has engaged in a deceptive act or practice in violation of New York General Business Law Section 349.
-
National Basketball Association:
- and its 30 member teams in a declaratory class action lawsuit against the National Basketball Players Association and all NBA players, filed in the Southern District of New York. The lawsuit seeks to establish, among other things, that the NBA’s lockout does not violate federal antitrust laws; and
- in an important ruling for the NBA and four NBA teams that had previously been members of the American Basketball Association (ABA) — the Denver Nuggets, the Indiana Pacers, the New Jersey Nets and the San Antonio Spurs — in obtaining dismissal of breach of contract claims filed against them by another former ABA team, the Spirits of St. Louis. On Oct. 19, 2009, Justice Barbara Kapnick of the commercial division of the New York State Supreme Court, New York County, granted the defendants’ motion and dismissed the Spirits’ claims without prejudice. The Spirits have appealed that decision to the Appellate Division, First Department, and filed a brief in support of its appeal, which is currently adjourned by stipulation until the court’s November 2010 calendar.
-
National Hockey League:
- as amicus curiae in Brady v. NFL, challenging the legality of the NFL lockout;
- in the highly publicized arbitration upholding its rejection of the 17-year, $102 million contract between Ilya Kovalchuk and the New Jersey Devils. After the National Hockey League Players’ Association filed a grievance in response to the league’s rejection of the contract, the parties presented their cases in arbitration. The arbitrator accepted the NHL’s argument that the last years of the contract were “reasonably unlikely” to be performed, ruling that the contract therefore constituted a “circumvention” of the parties’ collective bargaining agreement;
- in a dispute in the U.S. Bankruptcy Court for the District of Arizona in connection with the proposed sale of the Phoenix Coyotes. Skadden successfully argued that the U.S. Bankruptcy Court could not be used to decide ownership control and the relocation of teams. The court held that the NHL has the right under its constitution for its board of governors to consent to a transfer of ownership and any potential relocation of the team to Ontario. The court found that these consent rights could not be set aside under the bankruptcy laws or the antitrust laws, and the judge rejected the sale; and
- in the successful resolution of a lawsuit brought before the U.S. District Court for the Southern District of New York by Madison Square Garden L.P. (MSG) (the owner of the New York Rangers), over the operation of the New York Rangers team website. The Southern District of New York denied MSG’s request for a preliminary injunction and the U.S. Court of Appeals affirmed the district court’s denial. The lawsuit returned to the Southern District of New York, where most of MSG’s claims were dismissed, and the NHL and MSG reached a settlement.
-
National Football League:
- in a lawsuit in the U.S. District Court for the District of New Jersey alleging tort, contract and RICO claims in connection with the New England Patriots’ alleged videotaping of New York Jets coaches and players during a game at Giants Stadium. The lawsuit was dismissed with the court holding that the plaintiff received exactly what he paid for — the right to view an NFL football game at Giants Stadium — and could not maintain an action based on his subjective expectations about the fairness of the game. The Third Circuit recently affirmed the district court’s dismissal, and the U.S. Supreme Court denied the plaintiff’s petition for writ of certiorari.
- a non-public DOJ investigation regarding derivatives trading information.
- two non-public investigations in the EU regarding derivatives trading information and derivatives clearing, respectively.
- several investigations by the Federal Trade Commission in the pharmaceutical industry.
- a DOJ investigation in the air cargo transportation industry.
- a grand jury investigation involving ocean transportation in domestic trades.
- a DOJ civil non-merger investigation of competitive issues in the New York City electricity capacity market.
- two non-public multinational cartel investigations of an electronic components manufacturer.
- a non-public multinational cartel investigation of a transportation company.
- a grand jury investigation conducted by the Office of the Attorney General of New Jersey into fuel surcharges of a transportation company.
- an investigation by the Department of Justice into hiring practices in the high-tech industry.
- GlaxoSmithKline plc in the successful appeal before the EU General Court and subsequently the EU Court of Justice against a Commission decision finding that GlaxoSmithKline’s pricing policy violated Article 101 by restricting parallel imports between EU Member States that, according to the Commission, was “tantamount to an export ban.”
- Horizon Lines in a grand jury investigation involving ocean transportation in domestic trades.
- Intel Corporation in relation to the investigation by the European Commission concerning loyalty rebates and other conduct related to pricing that it alleged constituted an abuse of Intel’s alleged dominant position in the market for x86 CPUs. Skadden also is involved in the appeal against the Commission decision that is currently pending before the EU General Court.
- several large, multinational firms in international cartel proceedings that span jurisdictions across different continents. Skadden has successfully assisted companies in obtaining conditional immunity with the European Commission and other competition law agencies, ensuring close coordination of contacts with the different competition law agencies and a seamless representation across continents where agencies increasingly interact. Skadden is also advising companies on issues of parental liability for collusive conduct, an area of considerable interest and controversy in the EU given the Commission’s presumption of parental liability for wholly owned subsidiaries.
Our Antitrust Group - recognized as one of the top practices by publications such as Chambers USA (2013) and Chambers Global: The World's Leading Lawyers for Business (2013) - handles many of the most significant competition issues affecting businesses today. From large-scale, high-profile business combinations to major litigations to enforcement actions, clients trust us to provide experienced and coordinated real-time advice.
M&A
Recent M&A transactions that called upon our antitrust capabilities include Alcatel/Lucent Technologies, Toshiba Corporation/Westinghouse Electric Company and Arcelor S.A./Mittal Steel. The firm’s attorneys appear regularly before the Antitrust Division of the Department of Justice, the Federal Trade Commission and state attorneys general concerning investigations of proposed mergers and acquisitions.
Litigation
Our attorneys work on criminal and civil cases in federal and state courts nationwide and regularly counsel clients in industries as diverse as entertainment, food and beverages, chemicals, pharmaceuticals, surface and air transportation, telecommunications, energy, insurance and retail marketing.
Defending clients accused of criminal violations of U.S. antitrust laws constitutes another important area of our practice. We represent clients, including most major investment banks in all phases of grand jury matters, as well as in trials, sentencings and appeals. In addition, Skadden assists many clients in the preparation and administration of programs to achieve full compliance with antitrust laws.
Sports
We have had leading roles in the vast majority of noteworthy sports cases for 20 years, representing the National Football League, the National Basketball Association, the National Hockey League and various sports teams in numerous antitrust-related matters. Skadden also has represented the leagues, and served as lead trial counsel, in a variety of litigations and dispute resolutions involving both antitrust and non-antitrust claims.
International
The firm’s European Union antitrust practice includes defending clients against the increasingly vigorous enforcement activities of the EU Commission. Skadden’s practice also includes counseling, litigating and regulatory advice on non-transactional matters. For example, review of distribution agreements, intellectual property licenses (e.g., patents, know-how, trademarks and copyrights), joint ventures and other cooperative arrangements.
The firm’s international antitrust attorneys advise on how to structure a transaction in order to minimize the antitrust and foreign investment notification costs and substantive risks.

Connect with us